Drager JM-105 Jaundice Meter

New

₹6,27,000₹895,00030% off

Specifications

Measurement Range : 0.0 – 20.0 mg/dL (0 – 340 µmol/L)
Accuracy (SEE) : ±1.5 mg/dL (>35 weeks) / ±1.6 mg/dL (24–34 weeks)
Light Source : Pulse xenon arc lamp
Sensors : Silicon photodiodes
Light Source Life : ~150,000 measurements
Battery : Internal NiMH
Measurements Per Charge : ~250
AC Adapter : Input : 100–240 V, 50/60 Hz / Output : 9 V DC, 500 mA
Dimensions : Width - 56 mm / Height - 168 mm / Depth - 45 mm
Weight : ~203 g
Data transfer : USB / HL7 / CSV
Operating Temperature : 10°C to 40°C
Humidity : 30% – 95% (non-condensing)

highlights

Accurate early detection of jaundice risk in newborns
Improves patient safety with rapid results
Enhances workflow by reducing time-consuming lab processes
Minimizes discomfort for infants and stress for parents
Provides cost-effective screening over device lifetime
Supports efficient jaundice management programs

in the box

JM-105 device unit
Charging / docking station
AC adapter
Reusable probe tip
User manual / Instructions for Use

Use Cases :

Routine neonatal jaundice screening in hospitals and NICUs
Identification of infants requiring serum bilirubin testing
Monitoring hyperbilirubinemia risk in early life
Supporting clinical decision-making for phototherapy
Reducing need for invasive blood sampling

Key Features :

Non-invasive bilirubin measurement (no blood draw required)
Suitable for preterm and full-term neonates (≥24 weeks gestation)
Fast results in seconds for quicker clinical decisions
Reusable probe tip (no disposables needed)
Hospital system connectivity for data transfer (EMR integration)
Integrated patient flagging system for risk tracking
Helps reduce laboratory workload and costs

Warranty

Seller

AA MEDIE QUIPLearn More

Product Description

The Dräger JM-105 is a non-invasive transcutaneous bilirubinometer designed for screening neonatal jaundice. It measures the yellowness of subcutaneous tissue in newborns to estimate bilirubin levels without requiring blood samples. It helps clinicians quickly identify at-risk infants (as early as 2...